What does CUSIP 586858102 represent in this 13F holders report?

CUSIP 586858102 is the security identifier for MNLO - MENLO THERAPEUTICS INC - COM used to aggregate holder disclosures.

How many institutions held MNLO - MENLO THERAPEUTICS INC - COM in Q2 2019?

56 institutional investors reported MNLO - MENLO THERAPEUTICS INC - COM for Q2 2019. Use the holders table for investor-level position and value details.

MENLO THERAPEUTICS INC - COM (MNLO)

CUSIP: 586858102

Q2 2019 13F Holders as of 30 Jun 2019

Type / Class: Equity / COM
Total 13F shares: 18,330,610
Share change: +671,093
Total reported value: $109,536,399
Price per share: $5.99
Number of holders: 56
Value change: +$3,882,364
Number of buys: 35
Number of sells: 15

Quarterly Holders Quick Answers

What is CUSIP 586858102?
CUSIP 586858102 identifies MNLO - MENLO THERAPEUTICS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2019
Previous quarter: Q1 2019

Recent filing periods for CUSIP 586858102:

Q3 2020 Q2 2020 Q1 2020 Q4 2019 Q3 2019 Q2 2019 Q1 2019 Q4 2018

Institutional Holders of MENLO THERAPEUTICS INC - COM (MNLO) as of Q2 2019

As of 30 Jun 2019, MENLO THERAPEUTICS INC - COM (MNLO) was held by 56 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 18,330,610 shares. The largest 10 holders included Vivo Capital, LLC, FIRST MANHATTAN CO, GREAT POINT PARTNERS LLC, venBio Partners LLC, JANUS HENDERSON GROUP PLC, BlackRock Inc., MANGROVE PARTNERS, BAKER BROS. ADVISORS LP, ORBIMED ADVISORS LLC, and JPMORGAN CHASE & CO. This page lists 56 institutional shareholders reporting positions in this security for the Q2 2019 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.